S. Ozono - Concepedia

Author

S. Ozono

Hamamatsu University School of Medicine

Also Known As

Eijiro Okajima, Ozono Satoru, S Ozono, S. Ozono, Satoru Ozono, Seiichiro Ozono

107

Publications

981

Citations

H-Index

Concepts

All Affiliations

Hamamatsu University School of Medicine The University of Tokyo Nara Medical University Kyushu University Kanagawa Dental University

About

S. Ozono is an author at Hamamatsu University School of Medicine specializing in medicine, urology, and nervous system.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	410
2	Social Sciences	4	4	65
3	Health Sciences	1	1	17
4	Public Health	1	1	73
5	Biochemistry	1	1	127

S. Ozono

Publications

805

Citations

H-Index

Page 1

	Year	Citations
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Kazushige Mori, Makoto Hasegawa, M Nishida, International Journal of Oncology Breast Cancer TissuesPathologyTumor BiologyAnti-cancer AgentMetabolism	2000	127
Tumor Doubling Time of Renal Cell Carcinoma Measured by CT: Collaboration of Japanese Society of Renal Cancer S. Ozono Japanese Journal of Clinical Oncology	2004	75
Bladder Cancer Working Group Report Yoshiyuki Kakehi, Y Hirao, W.J. Kim, Japanese Journal of Clinical Oncology Surgical OncologyBladder CancersEpidemiology Of CancerGenetic EpidemiologyCancer Risk Factors	2010	73
Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial Takeshi Ueda, Hirotsugu Uemura, Y. Tomita, Japanese Journal of Clinical Oncology	2013	71
A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients Hiroshi Okada, Sadao Kamidono, T. Yoshioka, British Journal of Urology	2000	48
A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study) Nobuaki Matsubara, Hirotsugu Uemura, Takefumi Satoh, Japanese Journal of Clinical Oncology	2014	35
The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer S. Ozono, Takeshi Ueda, Senji Hoshi, Japanese Journal of Clinical Oncology	2012	34
A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy Toshihiko Satoh, Hiroji Uemura, K. Tanabe, Japanese Journal of Clinical Oncology	2014	32
Tumor Thrombus and Microvascular Invasion as Prognostic Factors in Renal Cell Carcinoma Shoji Samma, Katsunori Yoshida, S. Ozono, Japanese Journal of Clinical Oncology Macroscopic Tumor ThrombusUrologySurgical OncologyTumoral PathologyGenitourinary Cancer	1991	28
Successful Outcomes Using Combination Therapy of Interleukin-2 and Interferon- for Renal Cell Carcinoma Patients with Lung Metastasis Hideyuki Akaza, Koji Kawai, Tadashi Tsukamoto, Japanese Journal of Clinical Oncology	2010	24

Page 1